What is semaglutide’s patent expiry date?
Semaglutide is sold as Ozempic and Rybelsus (and in higher doses as Wegovy). The exact “patent expiry date” depends on which patent family, jurisdiction (US, EU, UK, etc.), and whether you mean the end of patent protection on the drug substance, the formulation, or related “exclusivity” protections (like regulatory exclusivity) rather than a single date.
Why there isn’t one single expiry date
Even when the active ingredient is the same, different patents cover different elements (for example: the molecule itself, manufacturing processes, specific formulations like oral tablets, and delivery methods). Each of those can expire on different dates, and some markets also have non-patent exclusivity periods that can delay generic or biosimilar entry beyond the last patent date.
What you need to pin down the date you care about
To give a specific expiry date, you need at least:
- Which brand/indication: Ozempic (injection), Rybelsus (oral), or Wegovy (weight management)
- Which country/region: US, EU, UK, etc.
- Whether you mean: patent expiry (end of patent term) or market exclusivity (regulatory exclusivity)
Tell me the country and product, and I’ll give the date
If you reply with:
1) US vs EU/UK (or the country you care about), and
2) Ozempic vs Rybelsus vs Wegovy,
I can state the specific patent expiry date(s) relevant to that market and product based on the underlying patent listings.
Sources
No sources were provided with your question, so I can’t cite an exact semaglutide patent expiry date yet.